Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Tonix Pharma
3811
Tonix Pharma
Technology
Biotechnology
Millions of Americans suffer from central nervous system (CNS) disorders. Tonix Pharmaceuticals is developing medicines to help. $TNXP
Suggest edits
Type
B2b
Raised
$8M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
Kickstarter
JPMorgan
Wired
Morgan Stanley
The New York Times
Companies in the same industry
BiOWiSH Technologies
Cytel Inc.
Aviir
CardioFocus
Rigel Pharmaceutical
Cerecin (Accera)
HealthFleet, Inc.
Phlexglobal
BioMedix
Confirm Biosciences
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$8,000,000
Post-IPO equity - 2017
Team Size
1–10
Employees
I work here
Location
New York
,
United States
Headquarters
Explore New York
$8,000,000
Post-IPO equity
biospace
Tonix Pharma Completes 8 Million Public Offering Of Common Stock
